|
|
||||||||
1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation1

* Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824; and
Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
Transforming growth factor-
1 is essential to maintain T cell homeostasis, as illustrated by multiorgan inflammation in mice deficient in TGF-
1 signaling. Despite the physiological importance, the mechanisms that TGF-
1 uses to regulate T cell expansion remain poorly understood. TGF-
1 signals through transmembrane receptor serine/threonine kinases to activate multiple intracellular effector molecules, including the cytosolic signaling transducers of the Smad protein family. We used Smad3-/- mice to investigate a role for Smad3 in IL-2 production and proliferation in T cells. Targeted disruption of Smad3 abrogated TGF-
1-mediated inhibition of anti-CD3 plus anti-CD28-induced steady state IL-2 mRNA and IL-2 protein production. CFSE labeling demonstrated that TGF-
1 inhibited entry of wild-type anti-CD3 plus anti-CD28-stimulated cells into cycle cell, and this inhibition was greatly attenuated in Smad3-/- T cells. In contrast, disruption of Smad3 did not affect TGF-
1-mediated inhibition of IL-2-induced proliferation. These results demonstrate that TGF-
1 signals through Smad3-dependent and -independent pathways to inhibit T cell proliferation. The inability of TGF-
1 to inhibit TCR-induced proliferation of Smad3-/- T cells suggests that IL-2 is not the primary stimulus driving expansion of anti-CD3 plus anti-CD28-stimulated T cells. Thus, we establish that TGF-
1 signals through multiple pathways to suppress T cell proliferation.
This article has been cited by other articles:
![]() |
A. Suto, D. Kashiwakuma, S.-i. Kagami, K. Hirose, N. Watanabe, K. Yokote, Y. Saito, T. Nakayama, M. J. Grusby, I. Iwamoto, et al. Development and characterization of IL-21-producing CD4+ T cells J. Exp. Med., June 9, 2008; 205(6): 1369 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Das and A. D. Levine TGF-{beta} Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction J. Immunol., February 1, 2008; 180(3): 1490 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Koth, B. Alex, S. Hawgood, M. A. Nead, D. Sheppard, D. J. Erle, and D. G. Morris Integrin beta6 Mediates Phospholipid and Collectin Homeostasis by Activation of Latent TGF-beta1 Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 651 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wrzesinski, Y. Y. Wan, and R. A. Flavell Transforming Growth Factor-{beta} and the Immune Response: Implications for Anticancer Therapy Clin. Cancer Res., September 15, 2007; 13(18): 5262 - 5270. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Ka, X.-R. Huang, H.-Y. Lan, P.-Y. Tsai, S.-M. Yang, H.-A. Shui, and A. Chen Smad7 Gene Therapy Ameliorates an Autoimmune Crescentic Glomerulonephritis in Mice J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1777 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tzachanis, L. Li, E. M. Lafuente, A. Berezovskaya, G. J. Freeman, and V. A. Boussiotis Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-{beta} signaling in activated T lymphocytes Blood, April 1, 2007; 109(7): 2944 - 2952. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Koehler, D. Kofler, A. Hombach, and H. Abken CD28 Costimulation Overcomes Transforming Growth Factor-{beta}-Mediated Repression of Proliferation of Redirected Human CD4+ and CD8+ T Cells in an Antitumor Cell Attack Cancer Res., March 1, 2007; 67(5): 2265 - 2273. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Villarino, C. M. Tato, J. S. Stumhofer, Z. Yao, Y. K. Cui, L. Hennighausen, J. J. O'Shea, and C. A. Hunter Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals J. Exp. Med., January 22, 2007; 204(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Carrier, J. Yuan, V. K. Kuchroo, and H. L. Weiner Th3 Cells in Peripheral Tolerance. I. Induction of Foxp3-Positive Regulatory T Cells by Th3 Cells Derived from TGF-beta T Cell-Transgenic Mice J. Immunol., January 1, 2007; 178(1): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Toda and C. A. Piccirillo Development and function of naturally occurring CD4+CD25+ regulatory T cells J. Leukoc. Biol., September 1, 2006; 80(3): 458 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Villarino, J. S. Stumhofer, C. J. M. Saris, R. A. Kastelein, F. J. de Sauvage, and C. A. Hunter IL-27 Limits IL-2 Production during Th1 Differentiation J. Immunol., January 1, 2006; 176(1): 237 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. McKarns and R. H. Schwartz Distinct Effects of TGF-{beta}1 on CD4+ and CD8+ T Cell Survival, Division, and IL-2 Production: A Role for T Cell Intrinsic Smad3 J. Immunol., February 15, 2005; 174(4): 2071 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Duthoit, D. J. Mekala, R. S. Alli, and T. L. Geiger Uncoupling of IL-2 Signaling from Cell Cycle Progression in Naive CD4+ T Cells by Regulatory CD4+CD25+ T Lymphocytes J. Immunol., January 1, 2005; 174(1): 155 - 163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |